CLIA Screen In-Viro™
13 Panel CSI Cup, CLIA Screen In-Vitro™ Rapid Drug Test Cup with Adulterants, 25/Box
- SKU:
- CSI-CUP-2135A3
- MPN:
- CSI-CUP-2135A3
Bulk discount rates
Below are the available bulk discount rates for each individual item when you purchase a certain amount
Quantity | Per Item |
1 - 3 | $122.50 |
4 - 11 | $118.25 |
12 - 19 | $114.00 |
20+ | $109.75 |
Description
13 Panel CSI Cup - CLIA Screen In-Vitro™ Drug Test Free Shipping 25/Case
The best selling 13 panel CSI Cup (CLIA Screen In-Vitro™) Multi-Panel Drug Test Cup is a No Step, fully integrated self contained multi-drug screening cup. No tipping or turning required. Read results in 5 minutes. The cup is FDA Cleared and CLIA Waived. This cup is a fast visual, competitive panel immunoassay that can be used for the simultaneous, qualitative detection of multiple drug metabolites at specific cutoff levels in human urine.
Features & Benefits
- CLIA Waived
- FDA 510(K) Approved
- Health Canada Approved
- Sold by the Case of 25 tests
- Includes "O-Ring seal" in cap for improved leak resistance
- New "Click Seal" cap is securely sealed with the “CLICK”
- No step cup
- Up to 99% Accurate
- Dual scale Temperature Strip verifies if urine is "fresh" and not diluted
- Adheres to the SAMHSA Cutoff Levels
- Immediate Results
- Shelf-life up to 24 months
- New easy to open top for the confirmation lab
Download & Print Reference Materials
CLIA Screen In Vitro Cup (CLIA Waived) Drug Test Package Insert
CLIA Screen In Vitro Cup (CLIA Waived) Drug Test Procedure Card
CLIA Screen In Vitro Cup (CLIA Waived) Drug Test Product Flyer
Thirteen Panel Configuration | |||
Item Number | Drugs Tested | Adulterants Tested | Regulatory Approvals |
CSI-CUP-2135A3 | AMP, BAR, BUP, BZO, COC, MET, MDMA, MOP-300, MTD, OXY, PCP, TCA, THC | OX - Oxidants SG - Specific gravity pH - pH Level |
CLIA Waived FDA 510(k) Cleared OTC - Over the Counter |
FDA 510(k) CLIA Waived Drug Detection Table in Urine | ||||
Drug Name / Description | Abbreviation | Cutoff | Detection Window* | Certifications / Approvals |
Amphetamine A schedule II drug available by prescription. Acute, higher dosages lead to euphoria, alertness and sense of energy and power. |
AMP | 500 ng/mL or 1000 ng/mL |
2 to 96 Hours | FDA 510k CLIA Waived OTC - Over the Counter |
Barbiturates Central nervous system depressants used therapeutically as sedatives hypnotics and anticonvulsants. |
BAR | 300 ng/mL | 2 to 72 Hours | FDA 510k CLIA Waived OTC - Over the Counter |
Benzodiazepines Frequently prescribed for the symptomatic treatment of anxiety and sleep disorders. |
BZO | 300 ng/mL | 2 to 96 Hours | FDA 510k CLIA Waived OTC - Over the Counter |
Buprenorphine / Suboxone A semi-synthetic opioid that has a longer duration of action than morphine and is used to treat moderate to severe pain. |
BUP | 10 ng/mL | 2 to 72 Hours | FDA 510k CLIA Waived OTC - Over the Counter |
Cocaine A potent central nervous system stimulant and local anesthetic that brings about extreme energy and restlessness. |
COC | 150 ng/mL or 300 ng/mL |
1 to 96 Hours | FDA 510k CLIA Waived OTC - Over the Counter |
Methadone Metabolite A controlled substance and is used for detoxification and maintenance of opiate-dependent patients. |
EDDP | 300 ng/mL | 1 to 72 Hours | FDA 510k CLIA Waived OTC - Over the Counter |
Ecstasy (D.L-Methylenedioxy-Methamphetamine) A designer drug that produces changes in the form of increased sensitivity to light, difficulty in focusing, and blurred vision. |
MDMA | 500 ng/mL | 2 to 96 Hours | FDA 510k CLIA Waived OTC - Over the Counter |
Cannabinoids / Marijuana When smoked or orally administered it produces euphoric effects. Users have impaired short term memory and slowed learning. |
THC | 50 ng/mL | 2 Hours to 40 Days | FDA 510k CLIA Waived OTC - Over the Counter |
Methadone A narcotic analgesic prescribed for the management of moderate to severe pain and for treatment of opiate dependence. |
MTD | 300 ng/mL | 3 to 72 Hours | FDA 510k CLIA Waived OTC - Over the Counter |
Methadone Metabolite A controlled substance and is used for detoxification and maintenance of opiate-dependent patients. |
EDDP | 300 ng/mL | 1 to 72 Hours | FDA 510k CLIA Waived OTC - Over the Counter |
Methamphetamine An addictive stimulant that affects the central nervous system. Can be taken orally, injected or inhaled. |
mAMP / MET | 500 ng/mL or 1000 ng/mL |
2 hours to 4 days | FDA 510k CLIA Waived OTC - Over the Counter |
Morphine / Opiates A drug derived from the opium poppy, including natural products morphine and codeine, and semi-synthetic drugs such as heroin. |
MOP / OPI | 300 ng/mL or 2000 ng/mL |
2 hours to 3 days | FDA 510k CLIA Waived OTC - Over the Counter |
Oxycodone A schedule II narcotic analgesic widely used in clinical medicine. Similar to morphine, in all respects, including its abuse and dependence. |
OXY | 100 ng/mL | 1 to 48 Hours | FDA 510k CLIA Waived OTC - Over the Counter |
Phencyclidine A hallucinogen, also known as Angel Dust, can be used in powder, capsule and tablet form. |
PCP | 25 ng/mL | 4 hours to 14 days | FDA 510k CLIA Waived OTC - Over the Counter |
Propoxyphene A mild narcotic analgesic found in various pharmaceutical preparations, usually as hydrochloride or napsylate salt. |
PPX | 300 ng/mL | 1 to 72 Hours | FDA 510k CLIA Waived OTC - Over the Counter |
Tricyclic Antidepressants / Nortriptyline Commonly used for treatment of depressive disorders. TCA overdose is the most common cause of death from prescription drugs. |
TCA | 1000 ng/mL | 2 Hours to 40 Days | FDA 510k CLIA Waived OTC - Over the Counter |
* Detection times are not guaranteed. This assay provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas Chromatogrphy/Mass Spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are indicated. |